Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/80268
DC Field | Value | Language |
---|---|---|
dc.contributor | Department of Biomedical Engineering | - |
dc.creator | Liu, C | - |
dc.creator | Yan, F | - |
dc.creator | Xu, YJ | - |
dc.creator | Zheng, HR | - |
dc.creator | Sun, L | - |
dc.date.accessioned | 2019-01-30T09:14:33Z | - |
dc.date.available | 2019-01-30T09:14:33Z | - |
dc.identifier.issn | 1555-4309 | - |
dc.identifier.uri | http://hdl.handle.net/10397/80268 | - |
dc.language.iso | en | en_US |
dc.publisher | John Wiley & Sons | en_US |
dc.rights | Copyright © 2018 Cheng Liu et al. This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | en_US |
dc.rights | The following publication Liu, C., Yan, F., Xu, Y.J., Zheng, H.R., & Sun, L. (2018). In vivo molecular ultrasound assessment of glioblastoma neovasculature with endoglin-targeted microbubbles. Contrast media & molecular imaging, UNSP 8425495, 1-10 is available at https://dx.doi.org/10.1155/2018/8425495 | en_US |
dc.title | In vivo molecular ultrasound assessment of glioblastoma neovasculature with endoglin-targeted microbubbles | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.spage | 1 | - |
dc.identifier.epage | 10 | - |
dc.identifier.doi | 10.1155/2018/8425495 | - |
dcterms.abstract | Objectives. Glioblastoma, as one of the most malignant cancer in the world, usually shows substantially increased angiogenesis. Endoglin (CD105), which is an alternative proangiogenic growth factor, has been remarkably upregulated on the proliferating glioblastoma neovasculature. However, little is known on the noninvasive assessment of the expression levels of CD105 during glioblastoma progression. Herein, we investigated the potential of the molecular ultrasound imaging for the noninvasive assessment of the expression levels of the biomarker CD105 during the glioblastoma progression. | - |
dcterms.abstract | Materials and Methods. The CD105-targeted perfluorocarbon-containing lipid-shelled microbubbles (MBs) were prepared. A parallel flow chamber was employed, in which the CD105-targeted and non-targeted MBs were tested across the CD105 +/- expression cell lines. In vivo molecular US imaging was conducted based on a subcutaneous xenograft tumor model (n = 9). Finally, the statistical analysis was conducted to quantitatively correlate the attachment numbers of MBs in the parallel flow chamber test with the CD105 expression levels of the cells in the flow cytometry test and the in vivo molecular ultrasound signals with the ex vivo expression levels of CD105 in the immunohistochemical test. | - |
dcterms.abstract | Results and Discussion. The attachment numbers of the CD105-targeted MBs significantly correlated with the CD105 expression levels of the cells in the parallel flow chamber test. There was a good correlation between the in vivo molecular ultrasound signals with the CD105-targeted MBs and the ex vivo expression levels of CD105 in the immunohistochemical test. The results indicate that the molecular US imaging is much potential to assess the progression of the glioblastoma neovasculature noninvasively. | - |
dcterms.accessRights | open access | en_US |
dcterms.bibliographicCitation | Contrast media & molecular imaging, 2018, 8425495, p. 1-10 | - |
dcterms.isPartOf | Contrast media & molecular imaging | - |
dcterms.issued | 2018 | - |
dc.identifier.isi | WOS:000448596800001 | - |
dc.identifier.eissn | 1555-4317 | - |
dc.identifier.artn | UNSP 8425495 | - |
dc.description.validate | 201901 bcrc | - |
dc.description.oa | Version of Record | en_US |
dc.identifier.FolderNumber | OA_IR/PIRA | en_US |
dc.description.pubStatus | Published | en_US |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Liu_Glioblastoma_Neovasculature_Endoglin-targeted.pdf | 4.66 MB | Adobe PDF | View/Open |
Page views
81
Last Week
1
1
Last month
Citations as of Apr 14, 2024
Downloads
28
Citations as of Apr 14, 2024
SCOPUSTM
Citations
10
Citations as of Apr 12, 2024
WEB OF SCIENCETM
Citations
7
Last Week
0
0
Last month
Citations as of Apr 18, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.